| High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial MJ Boeree, N Heinrich, R Aarnoutse, AH Diacon, R Dawson, S Rehal, ... The Lancet infectious diseases 17 (1), 39-49, 2017 | 382 | 2017 |
| Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic … JG Peter, LS Zijenah, D Chanda, P Clowes, M Lesosky, P Gina, N Mehta, ... The Lancet 387 (10024), 1187-1197, 2016 | 285 | 2016 |
| Rapid and Accurate Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert MTB/RIF Assay—A Clinical Validation Study A Rachow, A Zumla, N Heinrich, G Rojas-Ponce, B Mtafya, K Reither, ... PloS one 6 (6), e20458, 2011 | 243 | 2011 |
| Increased and expedited case detection by Xpert MTB/RIF assay in childhood tuberculosis: a prospective cohort study A Rachow, P Clowes, E Saathoff, B Mtafya, E Michael, EN Ntinginya, ... Clinical infectious diseases 54 (10), 1388-1396, 2012 | 194 | 2012 |
| Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients N Heinrich, R Dawson, J du Bois, K Narunsky, G Horwith, AJ Phipps, ... Journal of Antimicrobial Chemotherapy 70 (5), 1558-1566, 2015 | 97 | 2015 |
| The molecular bacterial load assay replaces solid culture for measuring early bactericidal response to antituberculosis treatment I Honeyborne, B Mtafya, PPJ Phillips, M Hoelscher, EN Ntinginya, ... Journal of clinical microbiology 52 (8), 3064-3067, 2014 | 83 | 2014 |
| The relationship between Mycobacterium tuberculosis MGIT time to positivity and cfu in sputum samples demonstrates changing bacterial phenotypes potentially … R Bowness, MJ Boeree, R Aarnoutse, R Dawson, A Diacon, C Mangu, ... Journal of Antimicrobial Chemotherapy 70 (2), 448-455, 2015 | 73 | 2015 |
| Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis molecular bacterial load assay W Sabiiti, K Azam, ECW Farmer, D Kuchaka, B Mtafya, R Bowness, ... Thorax 75 (7), 606-608, 2020 | 65 | 2020 |
| Phenotypic changes on Mycobacterium tuberculosis-specific CD4 T cells as surrogate markers for tuberculosis treatment efficacy MIM Ahmed, NE Ntinginya, G Kibiki, BA Mtafya, H Semvua, S Mpagama, ... Frontiers in immunology 9, 2247, 2018 | 56 | 2018 |
| Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania I Kroidl, P Clowes, K Reither, B Mtafya, G Rojas-Ponce, EN Ntinginya, ... European Respiratory Journal 46 (3), 761-770, 2015 | 55 | 2015 |
| Performance of the Xpert® MTB/RIF assay in an active case-finding strategy: a pilot study from Tanzania EN Ntinginya, SB Squire, KA Millington, B Mtafya, E Saathoff, N Heinrich, ... The International journal of tuberculosis and lung disease 16 (11), 1468-1470, 2012 | 41 | 2012 |
| Why being an expert–despite xpert–remains crucial for children in high TB burden settings JM Bacha, K Ngo, P Clowes, HR Draper, EN Ntinginya, A DiNardo, ... BMC infectious diseases 17, 1-8, 2017 | 38 | 2017 |
| Molecular bacterial load assay concurs with culture on NaOH-induced loss of Mycobacterium tuberculosis viability B Mtafya, W Sabiiti, I Sabi, J John, E Sichone, NE Ntinginya, SH Gillespie Journal of clinical microbiology 57 (7), 10.1128/jcm. 01992-18, 2019 | 36 | 2019 |
| Tuberculosis bacteria detection and counting in fluorescence microscopy images using a multi-stage deep learning pipeline M Zachariou, O Arandjelović, W Sabiiti, B Mtafya, D Sloan Information 13 (2), 96, 2022 | 26 | 2022 |
| Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settings W Sabiiti, B Mtafya, D Kuchaka, K Azam, S Viegas, A Mdolo, ECW Farmer, ... The International Journal of Tuberculosis and Lung Disease 20 (8), 1004-1009, 2016 | 17 | 2016 |
| Pan African Consortium for the Evaluation of Anti-tuberculosis Antibiotics. The molecular bacterial load assay replaces solid culture for measuring early bactericidal response … I Honeyborne, B Mtafya, PPJ Phillips, M Hoelscher, EN Ntinginya, ... J Clin Microbiol 52 (8), 3064-3067, 2014 | 17 | 2014 |
| PanACEA consortium (2017) High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: A multi-arm, multi-stage randomised controlled trial MJ Boeree, N Heinrich, R Aarnoutse, AH Diacon, R Dawson, S Rehal, ... Lancet Infect Dis 17, 39-49, 0 | 17 | |
| Mycobactericidal effects of different regimens measured by molecular bacterial load assay among people treated for multidrug-resistant tuberculosis in Tanzania PM Mbelele, EA Mpolya, E Sauli, B Mtafya, NE Ntinginya, KK Addo, ... Journal of clinical microbiology 59 (4), 10.1128/jcm. 02927-20, 2021 | 13 | 2021 |
| A tuberculosis molecular bacterial load assay (TB-MBLA) W Sabiiti, B Mtafya, DA De Lima, E Dombay, VO Baron, K Azam, ... JoVE (Journal of Visualized Experiments), e60460, 2020 | 13 | 2020 |
| Molecular bacterial load assay: a fast and accurate means for monitoring tuberculosis treatment response W Sabiiti, N Ntinginya, D Kuchaka, K Azam, E Kampira, B Mtafya, ... BMJ Global Health 2 (Suppl 2), 2017 | 10 | 2017 |
